Clinical Trial Update: Cetuximab Plus P-HDFL for the First-line Treatment of Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 results update evaluating cetuximab in combination with the P-HDFL regimen as first-line therapy for advanced gastric cancer. The update reports on effi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• P-HDFL (P-HDFL)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED